Resverlogix Corp. (TSX: RVX)
RVX trades on the Toronto Stock Exchange in Life Sciences, headquartered in Alberta. Numbers below come from the TMX issuer list, Yahoo Finance closes and the Bank of Canada rate, each with its source.
Issuer list, sector and C$ market cap: TMX Group TSX and TSXV listed companies, as of October 31, 2026. US$ figures convert C$ at 1.4257 C$ per US$, the Bank of Canada daily rate for November 13, 2026. Close and returns: Yahoo Finance daily closes for RVX.TO, last bar 2026-11-13, computed by MarginsX.
Profile
| Field | Value |
|---|---|
| Ticker | RVX on the Toronto Stock Exchange |
| Yahoo symbol | RVX.TO |
| Sector | Life Sciences |
| Headquarters | Alberta |
| Listed | 2005-01-17 |
| Listing type | TSXV Grad |
| Shares outstanding | 344,286,709 |
| Also listed on | No interlisting on the TMX list |
| Index membership | Not in an S&P/TSX index per the TMX list |
| SEC CIK | No SEC filer matched on exact name with a Canadian address or US interlisting |
| Website | No company website on record |
Returns
| Window | Return |
|---|---|
| 1 day | 0.0% |
| 1 week | 0.0% |
| 1 month | -11.1% |
| 3 months | -27.3% |
| 6 months | -20.0% |
| Year to date | -20.0% |
| 1 year | -20.0% |
| From 52-week high | -42.9% |
| 52-week range | C$0.0700 to C$0.1400 |
Links
SEDAR+ is linked for searching only; nothing on this page is taken from it.
Recent Canadian filings by type
68 documents in 6 types. Each title links to the document at its source.
Annual financial statements (5)
| Document | Type | Filed |
|---|---|---|
| Financial Statement Q4 2025 Period Q4 2025 | Annual financial statements | 2025-12-31 |
| Financial Statement Q4 2024 Period Q4 2024 | Annual financial statements | 2024-12-31 |
| Financial Statement Q4 2023 Period Q4 2023 | Annual financial statements | 2023-12-31 |
| Financial Statement Q4 2022 Period Q4 2022 | Annual financial statements | 2022-12-31 |
Interim financial statements (18)
| Document | Type | Filed |
|---|---|---|
| November 13, 2026 : Financial Statement Q3 2026 Period Q3 2026 | Interim financial statements | 2026-11-13 |
| Financial Statement Q2 2026 Period Q2 2026 | Interim financial statements | 2026-06-30 |
| Financial Statement Q1 2026 Period Q1 2026 | Interim financial statements | 2026-03-31 |
| Financial Statement Q3 2025 Period Q3 2025 | Interim financial statements | 2025-09-30 |
MD&A (24)
| Document | Type | Filed |
|---|---|---|
| MD&A Q4 2025 Period Q4 2025 | MD&A (annual) | 2025-12-31 |
| MD&A Q4 2024 Period Q4 2024 | MD&A (annual) | 2024-12-31 |
| MD&A Q4 2023 Period Q4 2023 | MD&A (annual) | 2023-12-31 |
| MD&A Q4 2022 Period Q4 2022 | MD&A (annual) | 2022-12-31 |
Annual information form (6)
| Document | Type | Filed |
|---|---|---|
| Annual Information Form 2025 Period Q4 2025 | Annual information form | 2025-12-31 |
| Annual Information Form 2024 Period Q4 2024 | Annual information form | 2024-12-31 |
| Annual Information Form 2023 Period Q4 2023 | Annual information form | 2023-12-31 |
| Annual Information Form 2022 Period Q4 2022 | Annual information form | 2022-12-31 |
Management information circular / proxy (11)
| Document | Type | Filed |
|---|---|---|
| Annual Meeting of Shareholders - Notice of Meeting and Management Information Circular Period Q2 2026 | Management information circular | 2026-05-21 |
| Annual Meeting of Shareholders - Notice of Meeting and Management Information Circular Period Q1 2025 | Management information circular | 2025-05-23 |
| Annual Meeting of Shareholders - Notice of Meeting and Management Information Circular 2024 Period Q2 2024 | Management information circular | 2024-07-10 |
| Annual Meeting of Shareholders - Notice of Meeting and Management Information Circular Period Q2 2023 | Management information circular | 2023-05-16 |
Other (4)
| Document | Type | Filed |
|---|---|---|
| Presentation | Investor presentation | 2026-06-25 |
| Fact Sheet Period FY2024 | Investor presentation | 2024-11-14 |
| Financial Statements | Financial statements (period not stated) | 2020-12-31 |
| Annual and Special Meeting of Shareholders - Notice-and-Access Notification | Other | No date |
Sources: Company investor-relations website (links only, documents not copied). Documents filed only on SEDAR+ are not copied here; search SEDAR+ for the full record.
Trading halts
No CIRO halt notices for this company in our data.
Source: Canadian Investment Regulatory Organization (CIRO), Halts/Resumptions newsroom, notices since 2024-10-15.
Upcoming events
No upcoming earnings date, call or meeting announced in the SEC filings and newswire releases we read.
Source: dates read from the company's SEC filings and newswire releases; each row links to the announcement.
US private placements (SEC Form D)
| Filed | Securities | Sold | Offered | Filing |
|---|---|---|---|---|
| 2011-12-01 | Equity | US$1.8M | US$1.8M | SEC EDGAR |
| 2011-06-21 | Equity, Option To Acquire | US$10.5M | US$10.5M | SEC EDGAR |
Source: SEC EDGAR Form D filings matched on exact issuer name. Amounts are US$ as filed.
Peers in Life Sciences
| Ticker | Company | Exchange | Market cap (C$) | 1 month | 1 year |
|---|---|---|---|---|---|
| ROMJ | Rubicon Organics Inc. | TSXV | C$25.8M | -4.4% | -20.4% |
| CHER | Cheelcare Inc. | TSXV | C$27.0M | -3.0% | +45.6% |
| PINK | Perimeter Medical Imaging AI Inc. | TSXV | C$27.5M | -31.8% | -16.7% |
| LABS | MediPharm Labs Corp. | TSX | C$27.8M | -7.1% | -7.1% |
| ZYUS | ZYUS Life Sciences Corporation | TSXV | C$29.8M | -20.0% | -42.9% |
The app has the price chart, every filing, private raises and the full peer set for RVX.
Open in the app